Cargando…
Monitoring of Sotrovimab-Levels as Pre-Exposure Prophylaxis in Kidney Transplant Recipients Not Responding to SARS-CoV-2 Vaccines
Background Sotrovimab, a monoclonal antibody against SARS-CoV-2, is used as a pre-exposition prophylaxis (PrEP) against COVID-19, but monitoring strategies using routine test systems have not been defined. Methods Twenty kidney transplant recipients without antibodies after vaccination received 500...
Autores principales: | Aschauer, Constantin, Heinzel, Andreas, Stiasny, Karin, Borsodi, Christian, Hu, Karin, Koholka, Jolanta, Winnicki, Wolfgang, Kainz, Alexander, Haslacher, Helmuth, Oberbauer, Rainer, Reindl-Schwaighofer, Roman, Weseslindtner, Lukas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459887/ https://www.ncbi.nlm.nih.gov/pubmed/37631967 http://dx.doi.org/10.3390/v15081624 |
Ejemplares similares
-
SARS-CoV-2 Omicron BA.1/BA.2 Neutralization up to 8 Weeks After PrEP With Sotrovimab or Cilgavimab/Tixagevimab
por: Stiasny, Karin, et al.
Publicado: (2022) -
Effects of Reduced-Dose Anti-Human T-Lymphocyte Globulin on Overall and Donor-Specific T-Cell Repertoire Reconstitution in Sensitized Kidney Transplant Recipients
por: Aschauer, Constantin, et al.
Publicado: (2022) -
ImmunoDataAnalyzer: a bioinformatics pipeline for processing barcoded and UMI tagged immunological NGS data
por: Vetter, Julia, et al.
Publicado: (2022) -
Three-Month Follow-Up of Heterologous vs. Homologous Third SARS-CoV-2 Vaccination in Kidney Transplant Recipients: Secondary Analysis of a Randomized Controlled Trial
por: Heinzel, Andreas, et al.
Publicado: (2022) -
Corrigendum: Three-Month follow-up of heterologous vs. homologous third SARS-CoV-2 vaccination in kidney transplant recipients: Secondary analysis of a randomized controlled trial
por: Heinzel, Andreas, et al.
Publicado: (2022)